Chemical Compound

Valsartan; (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic acid; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; CGP 48933; Cardopan; Diovan; Nisis; Tareg; Valsarect; Valsartanin

CAS Registry Number 137862-53-4
Valsartan; (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic acid; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; CGP 48933; Cardopan; Diovan; Nisis; Tareg; Valsarect; Valsartanin 结构式
Primary record

Valsartan; (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic acid; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; CGP 48933; Cardopan; Diovan; Nisis; Tareg; Valsarect; Valsartanin

库存
1,169 克
纯度
98.8 %
CAS
137862-53-4

化合物标识与属性

CAS
137862-53-4
PubChem CID
60846
SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
Canonical SMILES
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C

名称与同义词

  • valsartan
  • Diovan
  • 137862-53-4
  • Tareg
  • Provas
  • Exforge
  • Nisis
  • Prexxartan
  • Kalpress
  • Miten
  • Vals
  • ent-Valsartan
  • walsartan
  • L-Valsartan
  • Valsarran
  • Valzaar
  • Valtan
  • cardopan
  • valsartanin
  • valsartanum
  • Diovan Hct
  • Valpression
  • Valsartana
  • Valsaltan
  • Varexan
  • [3H]valsartan
  • Mixture Name
  • CGP 48933
  • Valsartan RS
  • Valsartan CRS
  • Valtan;
  • Diovan (TN)
  • Diovan, Valsartan
  • valsartan (Diovan)
  • Valsartan [USAN:INN]
  • Valzaar (TN)
  • Valtan (TN)
  • CGP-48933
  • Valsartan (Standard)
  • CEPA brand of valsartan
  • Lacer brand of valsartan
  • Sanol brand of valsartan
  • Esteve brand of valsartan
  • RefChem:6344
  • Aventis brand of valsartan
  • Schwarz brand of valsartan
  • Spectrum_001796
  • VALSARTAN [INN]
  • VALSARTAN [JAN]
  • Novartis brand of valsartan
  • VALSARTAN [MI]
  • MFCD00865840
  • AC1Q5QIK
  • VALSARTAN [HSDB]
  • VALSARTAN [USAN]
  • Spectrum2_001120
  • Spectrum3_001831
  • Spectrum4_000749
  • Spectrum5_001582
  • 80M03YXJ7I
  • CHEMBL1069
  • UNII-80M03YXJ7I
  • VALSARTAN [VANDF]
  • C24H29N5O3
  • D04HSR
  • D06UDG
  • Prexxartan (oral solution)
  • VALSARTAN [MART.]
  • AC1L1U1M
  • SCHEMBL2542
  • VALSARTAN [USP-RS]
  • VALSARTAN [WHO-DD]
  • CHEBI:9927
  • BSPBio_003501
  • DTXSID6023735
  • GTPL593
  • KBioGR_001078
  • KBioSS_002289
  • Valsartan (1708762)
  • VALSARTAN [EMA EPAR]
  • DAFIRO COMPONENT VALSARTAN
  • HSDB 7519
  • MLS000759423
  • MLS001424088
  • Valsartan (JAN/USAN/INN)
  • BIDD:GT0345
  • NSC-758927
  • SCHEMBL678231
  • SPECTRUM1505209
  • SPBio_001260
  • Valsartan - Bio-X trade mark
  • COPALIA COMPONENT VALSARTAN
  • EXFORGE COMPONENT VALSARTAN
  • IMPRIDA COMPONENT VALSARTAN
  • Valsartan (JP18/USP/INN)
  • Valsartan [USAN:USP:INN:BAN]
  • ENTRESTO COMPONENT VALSARTAN
  • GTPL3937
  • orb1300528
  • VALTURNA COMPONENT VALSARTAN
  • VALSARTAN [EP IMPURITY]
  • VALSARTAN [ORANGE BOOK]
  • SCHEMBL29406387
  • VALSARTAN [EP MONOGRAPH]
  • Valsartan, >=98% (HPLC)
  • ERK5-3M18
  • KBio2_002287
  • KBio2_004855
  • KBio2_007423
  • KBio3_003006
  • KS-00000ISS
  • C09CA03
  • EZR-104
  • VAL-489
  • VALSARTAN [USP MONOGRAPH]
  • (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
  • ACWBQPMHZXGDFX-QFIPXVFZSA-N
  • DAFIRO-HCT COMPONENT VALSARTAN
  • COPALIA-HCT COMPONENT VALSARTAN
  • DTXCID801508574
  • GLXC-05207
  • HMS1922L21
  • HMS2051L12
  • HMS2093K22
  • HMS2232F05
  • HMS3651E04
  • HMS3715P12
  • IMPRIDA-HCT COMPONENT VALSARTAN
  • Pharmakon1600-01505209
  • 48933, CGP
  • ACT02671
  • ALBB-038653
  • BCP05184
  • CGP48933
  • CID60846
  • MSK10065
  • ZINC3875259
  • AGSAV301 COMPONENT VALSARTAN
  • ANW-49040
  • BDBM50049186
  • CID:60846
  • EBC-11260
  • HY-18204R
  • NP2632
  • NSC758927
  • s1894
  • Valsartan for system suitability CRS
  • DIOVAN HCT COMPONENT VALSARTAN
  • N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
  • Valsartan for peak identification CRS
  • AKOS015914315
  • AKOS015994698
  • C24-H29-N5-O3
  • EXFORGE HCT COMPONENT VALSARTAN
  • (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
  • AC-4543
  • AM90287
  • AN-7255
  • CB10988
  • CCG-101028
  • CCG-221275
  • CS-1967
  • DB00177
  • DS-1248
  • FV28662
  • KS-1194
  • NC00278
  • NSC 758927
  • RTR-031794
  • VA11929
  • NCGC00178027-08
  • NCGC00178027-11
  • NCGC00178027-19
  • 137863-60-6
  • BC204156
  • BR-58790
  • BV164506
  • CPD000466318
  • HY-18204
  • I997
  • L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
  • SAM001246581
  • SC-00971
  • SMR000466318
  • EC 604-045-2
  • SBI-0206738.P001
  • SID:283537531
  • AB0013966
  • AB2000354
  • J550.722G
  • LS-161334
  • ST2408288
  • TL8000869
  • TR-031794
  • B2214
  • FT-0631156
  • FT-0675772
  • SW197658-2
  • V-120
  • V0112
  • N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
  • 4997-EP2270011A1
  • 4997-EP2272841A1
  • 4997-EP2277879A1
  • 4997-EP2295406A1
  • 4997-EP2295422A2
  • 4997-EP2298772A1
  • 4997-EP2298776A1
  • 4997-EP2298779A1
  • 4997-EP2301923A1
  • 4997-EP2301931A1
  • 4997-EP2301936A1
  • 4997-EP2305219A1
  • 4997-EP2308562A2
  • 4997-EP2308839A1
  • 62V534
  • D00400
  • J10013
  • N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
  • S-6418
  • AB00639940-06
  • AB00639940-08
  • AB00639940_09
  • AB00639940_11
  • EN300-6482022
  • A807313
  • C081489
  • F036602
  • L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
  • Q155472
  • SR-05000001928
  • SR-05000001928-1
  • Valsartan for Peak Identification CRS (Y0001131)
  • Valsartan for System Suitability CRS (Y0001145)
  • (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
  • BRD-K45158365-001-02-3
  • BRD-K45158365-001-05-6
  • BRD-K45158365-001-10-6
  • BRD-K45158365-001-11-4
  • I14-41498
  • N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
  • 137862-87-4
  • D000068756
  • N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
  • Z1379303659
  • Valsartan Working Standard (Secondary Reference Standard)
  • Valsartan, European Pharmacopoeia (EP) Reference Standard
  • N-[4-[2-(1H-Tetrazol-5-yl)phenyl]benzyl]-N-valeryl-L-valine
  • N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine
  • Valsartan, United States Pharmacopeia (USP) Reference Standard
  • (2S)-3-Methyl-2-(pentanoyl{[2?-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}amino)butanoic acid
  • (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
  • N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine
  • N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE
  • N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine
  • (-)-N-Pentanoyl-N-[2 -(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine
  • (2~{S})-3-methyl-2-[pentanoyl-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
  • (2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
  • (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid
  • (S)-N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-methyl)-valine
  • N-(1-Oxopentyl)-N-[4-[2-(1H-tetrazol-5-yl)phenyl]benzyl]-L-valine
  • N-[4-[2-(1H-Tetrazol-5-yl)phenyl]benzyl]-N-(1-oxopentyl)-L-valine
  • N-pentanoyl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-L-valine
  • N-Pentanoyl-N-[2 -(1H-tetrazol-5-yl)-4-biphenylylmethyl]-L-valine
  • N-Valeryl-N-[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-L-valine
  • Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material
  • (2S)-3-Methyl-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)butanoic acid
  • (2S)-N-Valeryl-N-[2 -(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-2-isopropylglycine
  • (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid
  • (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • 3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid
  • 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid
  • L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]methyl]-
  • L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI)
  • L-Valine,N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]methyl]- (9CI)
  • L-Valine,N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]methyl]-(9ci)
  • L-Valine,N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
  • N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-3-yl)methyl)-N-pentanoyl-L-valine
  • N-(1-Oxopentyl)-N-[[2 -(2H-tetrazol-5-yl)-4-biphenylyl]methyl]-L-valine
  • N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine
  • N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine
  • N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine
  • Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard
  • Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Valsartan, 99%, a nonpeptide angiotensin II AT1 receptor antagonist - 250MG 250mg
  • (2R)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Valsartan (R)-Enantiomer)
  • (2S)-3-Methyl-2-(N-((2'-(1H-1,2,3,4-tetrazol-5-yl)-(1,1-biphenyl)-4-yl)methyl)pentanamido)butanoic acid
  • (2S)-3-methyl-2-(N-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)pentanamido)butanoic acid
  • (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
  • (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
  • (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid.
  • (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid
  • (2S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid
  • (S)-2-(N-((2'-(1H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
  • (S)-2-(N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
  • (S)-2-[[[2 -(1H-Tetrazole-5-yl)-1,1 -biphenyl-4-yl]methyl](pentanoyl)amino]-3-methylbutanoic acid
  • (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid
  • (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
  • (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine
  • (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine
  • (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
  • 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid
  • 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
  • 943333-68-4
  • CGP48933, CGP-48933, CGP 48933, Valsartan, Diovan, Miten, Nisis, Prova, Tareg, Vals, Walsartan
  • L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; (S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
  • L-VALINE,N-(1-OXOPENTYL)-N-[[2''-(1H-TETRAZOL-5-YL)[1,1''-BIPHENYL]-3-YL]METHYL]-
  • U35
  • Valsartan; (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic acid; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; CGP 48933; Cardopan; Diovan; Nisis; Tareg; Valsarect; Valsartanin